{
  "spec_version": "3",
  "endpoint": "decisions",
  "stock_code": "4528",
  "company_name": "小野薬品工業",
  "content_lang": "ja",
  "meta_lang": "en",
  "canonical_url": "https://the-shashi.com/tse/4528/",
  "api_url": "/api/4528/decisions.json",
  "updated": "2026-08-05",
  "license": "© 2026 Yutaka Sugiura. All rights reserved.",
  "attribution": "The社史 (the-shashi.com) — https://the-shashi.com/tse/4528/",
  "count": 3,
  "description": "Index of this company's management decisions. One decision = one endpoint: follow api_url for the full dossier (background, the decision itself, outcome, quoted primary sources and references).",
  "decisions": [
    {
      "slug": "manufacturing-integration-1949",
      "url": "/tse/4528/decisions/manufacturing-integration-1949/",
      "api_url": "/api/4528/decisions/manufacturing-integration-1949.json",
      "year": 1949,
      "month": null,
      "type": "reorganization",
      "tags": [
        "bm-core-shift",
        "pf-vertical",
        "gv-family"
      ],
      "title": "日本有機化工の小野薬品工業への改称と、小野市兵衛商店の吸収合併による製販一本化",
      "subtitle": "創業以来つないだ薬種問屋の商号を、九代目小野市兵衛はなぜ製造会社の側へ畳んだか",
      "status": "implemented",
      "status_label": "実施"
    },
    {
      "slug": "bms-alliance-2011",
      "url": "/tse/4528/decisions/bms-alliance-2011/",
      "api_url": "/api/4528/decisions/bms-alliance-2011.json",
      "year": 2011,
      "month": 9,
      "type": "alliance",
      "tags": [
        "st-tech",
        "gl-expansion",
        "bm-model-shift"
      ],
      "title": "Bristol-Myers Squibbとの戦略提携による抗PD-1抗体の海外開発・販売権の供与",
      "subtitle": "自社に乏しい海外の臨床開発と販売網を、権利の分与と引き換えに大手へ委ねるか——相良暁社長はどう世界展開の道を開いたか",
      "status": "implemented",
      "status_label": "実施"
    },
    {
      "slug": "deciphera-acquisition-2024",
      "url": "/tse/4528/decisions/deciphera-acquisition-2024/",
      "api_url": "/api/4528/decisions/deciphera-acquisition-2024.json",
      "year": 2024,
      "month": 4,
      "type": "acquisition",
      "tags": [
        "ma-crossborder-out",
        "gl-entry",
        "pf-diversify-related"
      ],
      "title": "米Deciphera Pharmaceuticalsの約24億ドルでの買収と欧米販売網の取得",
      "subtitle": "オプジーボ後の柱をどこに求めるか——ロイヤルティ依存から欧米自社販売への転換",
      "status": "implemented",
      "status_label": "実施"
    }
  ],
  "by_type": [
    {
      "key": "acquisition",
      "count": 1,
      "url": "/api/4528/decisions/by-type/acquisition.json"
    },
    {
      "key": "alliance",
      "count": 1,
      "url": "/api/4528/decisions/by-type/alliance.json"
    },
    {
      "key": "reorganization",
      "count": 1,
      "url": "/api/4528/decisions/by-type/reorganization.json"
    }
  ],
  "by_decade": [
    {
      "key": "1940s",
      "count": 1,
      "url": "/api/4528/decisions/by-decade/1940s.json"
    },
    {
      "key": "2010s",
      "count": 1,
      "url": "/api/4528/decisions/by-decade/2010s.json"
    },
    {
      "key": "2020s",
      "count": 1,
      "url": "/api/4528/decisions/by-decade/2020s.json"
    }
  ]
}